Thaysa Tagliaferri has successfully defended her doctorate thesis on 15 January 2020. The title of her bi-nationally supervised thesis is: „EXPLORING THE CRISPR-CAS9 POTENTIAL TO REVERT BETA-LACTAM RESISTANCE IN CLINICALLY RELEVANT GRAM-NEGATIVE BACTERIA” and was supervised at the Institute of Medical Microbiology by Prof. Dr. Hans-Peter Horz and at the Universidade Federale de Minas Gerais, Brazil, Microbiology Department, by Prof. Dr. Simone Gonçalves dos Santos.
Für Presserückfragen wenden Sie sich bitte an:
Uniklinik RWTH Aachen
Stabsstelle Unternehmenskommunikation
Dr. Mathias Brandstädter
Tel. 0241 80-89893
kommunikationukaachende